Alternate-day & prolonged fasting studies

Three different interventions (do not average them)

Alternate-day fasting (ADF) usually means a feast day and a fast day in rotation. In clinics, the “fast” day is often modified: about 25% of usual calories (often 400–600 kcal in one sitting), not zero. True zero-calorie ADF exists; it is harder to stick to and less common in longer trials.

Whole-day or periodic fasting (the familiar 5:2) means two low-calorie or no-calorie days per week and more ordinary eating on the other five. Those two days are not the same as a daily 16-hour overnight gap.

Prolonged or extended fasting means one continuous stretch of about 48 hours or more, sometimes 72 hours, sometimes several days in a supervised clinic. A 48-hour fast is not “two 16:8s stacked.” Hydration, refeeding, and who should not attempt it change.

Reviews that pool all of these under “intermittent fasting” are answering a broader question than “should I try 5:2.” When you read a headline, check which protocol was actually assigned.

What was typically studied

ADF and 5:2 trials, like TRE trials, mostly enroll adults with overweight or obesity for weeks to a few months. A 2025 network review of 99 randomized fasting and diet trials (weeks to about a year) is the current map of the field, still not a lifetime follow-up.

Outcomes that show up most: body weight, some fat-mass and waist measures, lipids, blood pressure, glucose and insulin. Lean mass is measured less often and less carefully. Hunger, binge/restrict cycles, sleep, and mood are under-reported relative to how much they matter at home.

Prolonged-fast studies in humans are fewer, smaller, and more often run in supervised settings (clinic water or juice fasts, medical monitoring). They are a weak basis for an unsupervised 72-hour challenge at home. Many “autophagy” or “reset” claims about those days come from cells and animals, not from these trials. The older clinic story is Therapeutic fasting in the 19th–20th centuries. It is history, not a reason to copy a ward.

What trials tend to find

ADF usually produces weight loss versus unrestricted eating, often in the range of a few kilograms, or a few percent of body weight, over weeks to about three months. That is an energy-deficit story: feast days rarely fully make up the fast-day gap.

Compared with ordinary daily calorie restriction, ADF sometimes looks a little stronger on weight in shorter trials. The same 2025 review found ADF the only intermittent-fasting style with a small extra average loss versus continuous restriction (on the order of about one kilogram), and a small edge versus TRE. In trials that lasted 24 weeks or more, those extra differences mostly faded: the stricter patterns still beat eating without a plan; they did not clearly beat eating less on a regular schedule.

5:2 and other two-day-a-week patterns also beat unrestricted eating on weight. They have not consistently beaten ordinary calorie restriction. “Slightly better in some short ADF arms” is not “5:2 is medically superior.”

Lipids and blood pressure sometimes move with the weight. Glucose and HbA1c findings are mixed and are not a license to treat diabetes with a fast-day calendar. Lean mass can fall along with fat mass, a reminder that protein, resistance work, and not treating muscle as optional still matter when you eat.

Limits (read these as part of the result)

Adherence is the practical result. A day of ~500 kcal every other day is a different social and hunger load than skipping breakfast. People compensate on feast days, skip assigned fast days, or leave the study. Remaining averages can look tidier than the protocol people actually lived.

Who: same narrow enrollment as most TRE papers, adults with extra weight, often excluding pregnancy, underweight, eating-disorder history, and complex disease. Safety notes in Fundamentals still apply, more so here.

Modified vs zero: many “ADF works” papers used a small meal on the fast day. Copying a true water-only alternate day because a modified-ADF trial lost weight is a different intervention.

Prolonged fasts: small n, supervision, short follow-up, and almost no data on unsupervised multi-day challenges. Refeeding after several days is a medical topic, not a “first meal flex.” Clinic programs are not the same as an app timer left running.

Duration: extra kilograms in an 8–12 week ADF arm do not prove a better decade. Longer trials shrink the gap with ordinary dieting.

What this does not mean

It does not mean ADF or a 72-hour fast is the “real” version of intermittent fasting, or a promotion after 16:8. Daily windows, weekly fast days, and multi-day episodes are different tools with different costs.

It does not mean more fasting hours are a dose of autophagy or longevity. See the autophagy note. It does not mean you should copy a trial arm if you take glucose- or blood-pressure-lowering drugs, or if food has been a difficult area.

It does not mean a 24h or 48h preset on this timer is a studied protocol. Those buttons measure elapsed time for a plan you already chose, ideally with clinical advice when the plan is multi-day.

How this meets the timer

If you only wanted evidence for a daily window, stop at Part 2. Fundamentals still say: start near your overnight gap; delay OMAD and multi-day challenges; stop for warning signs. Nothing in the ADF literature reverses that order.

MyFastingClock’s 24h, 36h, 48h, and Open modes exist so a longer plan is not paywalled. Unlimited tracking is flexibility. It is not evidence that a 48-hour fast is the next research-backed step. Pair any longer session with the multi-day practice note, the stop note, and a clinician when that note says you should.